secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0000950170-24-017922
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q4 revenue $30.5M, FY revenue $130.4M; CCO Steve Williamson departs March 1
--------------------------------------------------------------------------------

- FY 2023 revenue $130.4M (+13% YoY); Q4 revenue $30.5M (-4.7% YoY) due to product revenue decline.
- Q4 gross margin 25.3% (non-GAAP 26.7%), up ~900 bps YoY; FY gross margin 22.2% (non-GAAP 23.6%).
- Tablo installed base 5,350 consoles exiting 2023; recurring revenue exceeded 50% of total revenue.
- 2024 guidance reaffirmed: revenue $145-153M (+12-18% YoY); non-GAAP gross margin low-30% range.
- CCO Steve Williamson to depart March 1, 2024 to become CEO of another public med device company; no dispute.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024017922/0000950170-24-017922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024017922/om-20240216.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-017922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer